Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition
- PMID: 3932214
- PMCID: PMC261995
- DOI: 10.1128/iai.50.2.577-582.1985
Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition
Abstract
Selected physiological parameters of 31 classic and rough Pseudomonas aeruginosa strains from respiratory tract cultures of patients with cystic fibrosis were examined. An association of a patient's clinical condition (good or poor) with strain physiology was made. Rough strains from patients in poor clinical condition demonstrated severe alterations in motility when compared with M-2, a highly motile and chemotactic burn strain. Of the 10 rough strains from patients in poor clinical condition, 70% lacked flagella, as determined by electron microscopy. The remaining few flagellated strains from this group exhibited weak motility both in soft agar and by the capillary assay. Their chemotactic response to three amino acids, when compared with that of strain M-2, was reduced approximately 30 to 90%. Classic strains from patients in poor clinical condition were less chemotactic than those from patients in good clinical condition. A majority of classic and rough strains from patients in good clinical condition were comparable to M-2 in both chemotaxis and motility. Changes in other physiological characteristics indicated by reduced growth rates, or auxotrophy, were seldom observed in the cystic fibrosis strains studied. The data suggest that host-selective pressures, associated primarily with patients with cystic fibrosis that are in poor clinical condition, result in the loss of factors related to invasiveness such as motility and chemotaxis. We propose that these results may reflect that there is a more general alteration in the cell envelope of cystic fibrosis strains.
Similar articles
-
Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa.Infect Immun. 1985 Nov;50(2):572-6. doi: 10.1128/iai.50.2.572-576.1985. Infect Immun. 1985. PMID: 3932213 Free PMC article.
-
Motility as a selective force in the reversion of cystic fibrosis-associated mucoid Pseudomonas aeruginosa to the nonmucoid phenotype in culture.Infect Immun. 1982 Aug;37(2):840-4. doi: 10.1128/iai.37.2.840-844.1982. Infect Immun. 1982. PMID: 6811443 Free PMC article.
-
Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization in cystic fibrosis.Infect Immun. 1990 Jun;58(6):1489-95. doi: 10.1128/iai.58.6.1489-1495.1990. Infect Immun. 1990. PMID: 2111280 Free PMC article.
-
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.Cochrane Database Syst Rev. 2013 Dec 23;(12):CD009530. doi: 10.1002/14651858.CD009530.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2016 Jan 21;(1):CD009530. doi: 10.1002/14651858.CD009530.pub3 PMID: 24363033 Updated. Review.
-
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.Cochrane Database Syst Rev. 2016 Jan 21;(1):CD009530. doi: 10.1002/14651858.CD009530.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2018 Sep 17;9:CD009530. doi: 10.1002/14651858.CD009530.pub4 PMID: 26797965 Updated. Review.
Cited by
-
Impairment in inflammasome signaling by the chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients results in an increase in inflammatory response.Cell Death Dis. 2021 Mar 4;12(3):241. doi: 10.1038/s41419-021-03526-w. Cell Death Dis. 2021. PMID: 33664232 Free PMC article.
-
Regulation of flagellar motility during biofilm formation.FEMS Microbiol Rev. 2013 Nov;37(6):849-71. doi: 10.1111/1574-6976.12018. Epub 2013 Apr 12. FEMS Microbiol Rev. 2013. PMID: 23480406 Free PMC article. Review.
-
Capillary electrophoresis-single-strand conformation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.J Clin Microbiol. 1999 Oct;37(10):3374-9. doi: 10.1128/JCM.37.10.3374-3379.1999. J Clin Microbiol. 1999. PMID: 10488211 Free PMC article.
-
Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis.J Clin Microbiol. 1989 Dec;27(12):2789-93. doi: 10.1128/jcm.27.12.2789-2793.1989. J Clin Microbiol. 1989. PMID: 2512326 Free PMC article.
-
Regulation of flagellar motor switching by c-di-GMP phosphodiesterases in Pseudomonas aeruginosa.J Biol Chem. 2019 Sep 13;294(37):13789-13799. doi: 10.1074/jbc.RA119.009009. Epub 2019 Jul 26. J Biol Chem. 2019. PMID: 31350333 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
